Jan Birger Fredrik Toernell

Directeur/Membre du Conseil chez ABLIVA AB

Profil

Jan Birger Fredrik Toernell currently works at Innoex AB, as Chief Executive Officer & Director, Innoext AB, as Chief Executive Officer & Director from 2011, Glactone Pharma AB, as Chairman from 2012, Glactone Pharma Development AB, as Chairman, Abliva AB, as Independent Director from 2017, Diaprost AB, as Director from 2012, Stayble AB, as Director, Lidds Pharma AB, as Deputy Director, the University of Gothenburg, as Professor, Aqilion AB, as Partner from 2012, and Sahlgrenska University, as Professor.
Dr. Toernell also formerly worked at Oncorena AB, as Chief Executive Officer, Oncorena Holding AB, as Chief Executive Officer, LIDDS AB, as Independent Chairman, Isofol Medical AB, as Chairman, Stayble Therapeutics AB, as Director, Hammars Bryggeri AB, as Director, AstraZeneca PLC, as Vice President-Global Strategy, and Puls AB, as Partner.
Dr. Toernell received his doctorate degree from the University of Gothenburg.

Postes actifs de Jan Birger Fredrik Toernell

Sociétés	Poste	Début
ABLIVA AB	Directeur/Membre du Conseil	27/04/2017
University of Gothenburg	Corporate Officer/Principal	-
Sahlgrenska University	Corporate Officer/Principal	-
Innoext AB	Directeur Général	01/07/2011
Lidds Pharma AB	Corporate Officer/Principal	-
Aqilion AB	Private Equity Investor	29/05/2012
Glactone Pharma AB	Président	01/07/2012
Stayble AB	Directeur/Membre du Conseil	-
Diaprost AB	Directeur/Membre du Conseil	01/06/2012
░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░	-

Anciens postes connus de Jan Birger Fredrik Toernell

Sociétés	Poste	Fin
░░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-
░░░░░░░ ░░░░░░░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-
░░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░	-
░░░░░░░░ ░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░	-
░░░░░░ ░░░░░░░ ░░	░░░░░░░░░░	-